BioCentury
ARTICLE | Clinical News

DynaGen regulatory update

May 10, 1993 7:00 AM UTC

DynaGen Inc. (DYGN) DynaGen Inc. (DYGN) has received FDA clearance to market ProCheck for use as a blind specimen test kit to obtain independent validation of drugs-of-abuse testing procedures conduc...